Inizio Ignite

Lilly Declares Second-Quarter 2015 Dividend

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

QIAGEN’s QuantiFERON-TB Gold Plus shows cost-effectiveness compared with TST

QIAGEN’s QuantiFERON-TB Gold Plus shows cost-effectiveness compared with TST...

Inizio Evoke Appoints Kristin Ryan as EVP to Lead AI Healthcare Innovation

Kristin Ryan Joins Inizio Evoke as EVP, AI Transformation...
- Advertisement -

INDIANAPOLIS, May 4, 2015 /PRNewswire/ — The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the second quarter of 2015 of $0.50 per share on outstanding common stock.

The dividend is payable June 10, 2015, to shareholders of record at the close of business on May 18, 2015.

About Eli Lilly and Company

Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at www.lilly.com and http://newsroom.lilly.com/social-channels.  F-LLY

Refer to: Lauren Zierke; lauren_zierke@lilly.com; (317) 277-6524

Eli Lilly and Company logo.

Logo – http://photos.prnewswire.com/prnh/20031219/LLYLOGO

SOURCE Eli Lilly and Company

Latest stories

Related stories

QIAGEN’s QuantiFERON-TB Gold Plus shows cost-effectiveness compared with TST

QIAGEN’s QuantiFERON-TB Gold Plus shows cost-effectiveness compared with TST...

Inizio Evoke Appoints Kristin Ryan as EVP to Lead AI Healthcare Innovation

Kristin Ryan Joins Inizio Evoke as EVP, AI Transformation...

Kindeva Announces Leadership Transition to Drive Strategic Growth

Kindeva, a global contract development and manufacturing organization (CDMO) and...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Translate »